Galmed Pharmaceuticals Quote - GLMD

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

3.05

Bid

2.50

Ask

3.57

Volume

72,055

2.89 Day's Range 3.318

2.56 52 Week Range 23.80

Market Cap

1.963M

Previous Close

3.07

Open

3.28

Last Trade

2.97

Last Trade Time

Financial Volume

US$ 222,897

VWAP

3.0934

Average Volume (3m)

99,387

Shares Outstanding

643,690

Dividend Yield

PE Ratio

-0.28

Earnings Per Share (EPS)

-10.74

Revenue

Net Profit

-6.91M

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aram... Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.galmedpharma.com

Headquarters

Tel Aviv, Center, Isr

Founded

Galmed Pharmaceuticals Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GLMD. The last closing price for Galmed Pharmaceuticals was US$3.07. Over the last year, Galmed Pharmaceuticals shares have traded in a share price range of US$ 2.56 to US$ 23.80.

Galmed Pharmaceuticals currently has 643,690 shares outstanding. The market capitalization of Galmed Pharmaceuticals is US$1.98 million. Galmed Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.28.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.28	10.1083032491	2.77	3.39	2.73	69330	3.0858612	CS
4	0.24	8.5409252669	2.81	3.39	2.56	45785	2.92447555	CS
12	-4.01	-56.7988668555	7.06	7.76	2.56	99387	3.98583132	CS
26	-1.012	-24.913835549	4.062	23.8	2.56	1467346	11.14860222	CS
52	-1.486	-32.7601410935	4.536	23.8	2.56	814230	10.57534922	CS
156	-371.35	-99.1853632479	374.4	392.382	2.56	372478	31.03236436	CS
260	-970.75	-99.6867940029	973.8	1302.75	2.56	292981	188.19943175	CS

GLMD - Frequently Asked Questions (FAQ)

What is the current Galmed Pharmaceuticals share price?

The current share price of Galmed Pharmaceuticals is US$ 3.05

How many Galmed Pharmaceuticals shares are in issue?

Galmed Pharmaceuticals has 643,690 shares in issue

What is the market cap of Galmed Pharmaceuticals?

The market capitalisation of Galmed Pharmaceuticals is USD 1.98M

What is the 1 year trading range for Galmed Pharmaceuticals share price?

Galmed Pharmaceuticals has traded in the range of US$ 2.56 to US$ 23.80 during the past year

What is the PE ratio of Galmed Pharmaceuticals?

The price to earnings ratio of Galmed Pharmaceuticals is -0.28

What is the reporting currency for Galmed Pharmaceuticals?

Galmed Pharmaceuticals reports financial results in USD

What is the latest annual profit for Galmed Pharmaceuticals?

The latest annual profit of Galmed Pharmaceuticals is USD -6.91M

What is the registered address of Galmed Pharmaceuticals?

The registered address for Galmed Pharmaceuticals is 16 TIOMKIN STREET, TEL AVIV, CENTER, 6578317

What is the Galmed Pharmaceuticals website address?

The website address for Galmed Pharmaceuticals is www.galmedpharma.com

Which industry sector does Galmed Pharmaceuticals operate in?

Galmed Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Symbol	Price	Vol.
MYSZMy Size Inc	US$ 4.2001 (211.12%)	120.01M
NVNINVNI Group Ltd	US$ 8.26 (209.36%)	76.64M
TPICTPI Composites Inc	US$ 2.45 (100.82%)	33.95M
ICGIntchains Group Ltd	US$ 8.77 (88.60%)	527.61k
HSDTHelius Medical Technologies Inc	US$ 0.884851 (84.34%)	120.4M
CYNCYNGN Inc	US$ 0.4603 (-71.41%)	27.91M
MTEMMolecular Templates Inc	US$ 0.1502 (-57.09%)	8.75M
PRFXPainReform Ltd	US$ 5.15 (-53.85%)	2.94M
GALTGalectin Therapeutics Inc	US$ 1.03 (-48.50%)	9.27M
BCABBioAtla Inc	US$ 0.6923 (-41.82%)	6.25M
EDBLEdible Garden AG Inc	US$ 0.24 (65.06%)	354.33M
NVDANVIDIA Corporation	US$ 134.70 (3.08%)	310.19M
APTOAptose Biosciences Inc	US$ 0.28 (64.51%)	306.25M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.606999 (6.49%)	293.22M
PLTRPalantir Technologies Inc	US$ 80.55 (8.54%)	281.23M

Symbol

Price

Vol.